Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents

Jack R. Cornelius, Antoine Douaihy, Oscar G. Bukstein, Dennis C. Daley, Scott D. Wood, Thomas M. Kelly, Ihsan M Salloum

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective: Behavioral therapies developed specifically for co-occurring disorders remain sparse, and such therapies for comorbid adolescents are particularly rare. This was an evaluation of the long-term (2-year) efficacy of an acute phase trial of manualized cognitive behavioral therapy/motivation enhancement therapy (CBT/MET) vs. naturalistic treatment among adolescents who had signed consent for a treatment study involving the SSRI antidepressant medication fluoxetine and CBT/MET therapy for comorbid major depressive disorder (MDD) and an alcohol use disorder (AUD). We hypothesized that improvements in depressive symptoms and alcohol-related symptoms noted among the subjects who had received CBT/MET would exceed that of those in the naturalistic comparison group that had not received CBT/MET therapy. Methods: We evaluated levels of depressive symptoms and alcohol-related symptoms at a two-year follow-up evaluation among comorbid MDD/AUD adolescents who had received an acute phase trial of manual-based CBT/MET (in addition to the SSRI medication fluoxetine or placebo) compared to those who had received naturalistic care. Results: In repeated measures ANOVA, a significant time by enrollment status difference was noted for both depressive symptoms and alcohol-related symptoms across the two-year time period of this study, with those receiving CBT/MET demonstrating superior outcomes compared to those who had not received protocol CBT/MET therapy. No significant difference was noted between those receiving fluoxetine vs. those receiving placebo on any outcome at any time point. Conclusions: These findings suggest long-term efficacy for an acute phase trial of manualized CBT/MET for treating comorbid MDD/AUD adolescents. Large multi-site studies are warranted to further clarify the efficacy of CBT/MET therapy among various adolescent and young adult comorbid populations.

Original languageEnglish
Pages (from-to)843-848
Number of pages6
JournalAddictive Behaviors
Volume36
Issue number8
DOIs
StatePublished - Aug 1 2011
Externally publishedYes

Fingerprint

Major Depressive Disorder
Cognitive Therapy
Alcohols
Fluoxetine
Therapeutics
Analysis of variance (ANOVA)
Antidepressive Agents
Underage Drinking
Depression
Placebos

Keywords

  • Adolescents
  • Alcohol use disorder
  • Cognitive behavioral therapy
  • Comorbidity
  • Major depression
  • Motivational enhancement therapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Toxicology
  • Medicine (miscellaneous)

Cite this

Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. / Cornelius, Jack R.; Douaihy, Antoine; Bukstein, Oscar G.; Daley, Dennis C.; Wood, Scott D.; Kelly, Thomas M.; Salloum, Ihsan M.

In: Addictive Behaviors, Vol. 36, No. 8, 01.08.2011, p. 843-848.

Research output: Contribution to journalArticle

Cornelius, Jack R. ; Douaihy, Antoine ; Bukstein, Oscar G. ; Daley, Dennis C. ; Wood, Scott D. ; Kelly, Thomas M. ; Salloum, Ihsan M. / Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. In: Addictive Behaviors. 2011 ; Vol. 36, No. 8. pp. 843-848.
@article{435502135dba4849a737dcf034eef594,
title = "Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents",
abstract = "Objective: Behavioral therapies developed specifically for co-occurring disorders remain sparse, and such therapies for comorbid adolescents are particularly rare. This was an evaluation of the long-term (2-year) efficacy of an acute phase trial of manualized cognitive behavioral therapy/motivation enhancement therapy (CBT/MET) vs. naturalistic treatment among adolescents who had signed consent for a treatment study involving the SSRI antidepressant medication fluoxetine and CBT/MET therapy for comorbid major depressive disorder (MDD) and an alcohol use disorder (AUD). We hypothesized that improvements in depressive symptoms and alcohol-related symptoms noted among the subjects who had received CBT/MET would exceed that of those in the naturalistic comparison group that had not received CBT/MET therapy. Methods: We evaluated levels of depressive symptoms and alcohol-related symptoms at a two-year follow-up evaluation among comorbid MDD/AUD adolescents who had received an acute phase trial of manual-based CBT/MET (in addition to the SSRI medication fluoxetine or placebo) compared to those who had received naturalistic care. Results: In repeated measures ANOVA, a significant time by enrollment status difference was noted for both depressive symptoms and alcohol-related symptoms across the two-year time period of this study, with those receiving CBT/MET demonstrating superior outcomes compared to those who had not received protocol CBT/MET therapy. No significant difference was noted between those receiving fluoxetine vs. those receiving placebo on any outcome at any time point. Conclusions: These findings suggest long-term efficacy for an acute phase trial of manualized CBT/MET for treating comorbid MDD/AUD adolescents. Large multi-site studies are warranted to further clarify the efficacy of CBT/MET therapy among various adolescent and young adult comorbid populations.",
keywords = "Adolescents, Alcohol use disorder, Cognitive behavioral therapy, Comorbidity, Major depression, Motivational enhancement therapy",
author = "Cornelius, {Jack R.} and Antoine Douaihy and Bukstein, {Oscar G.} and Daley, {Dennis C.} and Wood, {Scott D.} and Kelly, {Thomas M.} and Salloum, {Ihsan M}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.addbeh.2011.03.016",
language = "English",
volume = "36",
pages = "843--848",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents

AU - Cornelius, Jack R.

AU - Douaihy, Antoine

AU - Bukstein, Oscar G.

AU - Daley, Dennis C.

AU - Wood, Scott D.

AU - Kelly, Thomas M.

AU - Salloum, Ihsan M

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objective: Behavioral therapies developed specifically for co-occurring disorders remain sparse, and such therapies for comorbid adolescents are particularly rare. This was an evaluation of the long-term (2-year) efficacy of an acute phase trial of manualized cognitive behavioral therapy/motivation enhancement therapy (CBT/MET) vs. naturalistic treatment among adolescents who had signed consent for a treatment study involving the SSRI antidepressant medication fluoxetine and CBT/MET therapy for comorbid major depressive disorder (MDD) and an alcohol use disorder (AUD). We hypothesized that improvements in depressive symptoms and alcohol-related symptoms noted among the subjects who had received CBT/MET would exceed that of those in the naturalistic comparison group that had not received CBT/MET therapy. Methods: We evaluated levels of depressive symptoms and alcohol-related symptoms at a two-year follow-up evaluation among comorbid MDD/AUD adolescents who had received an acute phase trial of manual-based CBT/MET (in addition to the SSRI medication fluoxetine or placebo) compared to those who had received naturalistic care. Results: In repeated measures ANOVA, a significant time by enrollment status difference was noted for both depressive symptoms and alcohol-related symptoms across the two-year time period of this study, with those receiving CBT/MET demonstrating superior outcomes compared to those who had not received protocol CBT/MET therapy. No significant difference was noted between those receiving fluoxetine vs. those receiving placebo on any outcome at any time point. Conclusions: These findings suggest long-term efficacy for an acute phase trial of manualized CBT/MET for treating comorbid MDD/AUD adolescents. Large multi-site studies are warranted to further clarify the efficacy of CBT/MET therapy among various adolescent and young adult comorbid populations.

AB - Objective: Behavioral therapies developed specifically for co-occurring disorders remain sparse, and such therapies for comorbid adolescents are particularly rare. This was an evaluation of the long-term (2-year) efficacy of an acute phase trial of manualized cognitive behavioral therapy/motivation enhancement therapy (CBT/MET) vs. naturalistic treatment among adolescents who had signed consent for a treatment study involving the SSRI antidepressant medication fluoxetine and CBT/MET therapy for comorbid major depressive disorder (MDD) and an alcohol use disorder (AUD). We hypothesized that improvements in depressive symptoms and alcohol-related symptoms noted among the subjects who had received CBT/MET would exceed that of those in the naturalistic comparison group that had not received CBT/MET therapy. Methods: We evaluated levels of depressive symptoms and alcohol-related symptoms at a two-year follow-up evaluation among comorbid MDD/AUD adolescents who had received an acute phase trial of manual-based CBT/MET (in addition to the SSRI medication fluoxetine or placebo) compared to those who had received naturalistic care. Results: In repeated measures ANOVA, a significant time by enrollment status difference was noted for both depressive symptoms and alcohol-related symptoms across the two-year time period of this study, with those receiving CBT/MET demonstrating superior outcomes compared to those who had not received protocol CBT/MET therapy. No significant difference was noted between those receiving fluoxetine vs. those receiving placebo on any outcome at any time point. Conclusions: These findings suggest long-term efficacy for an acute phase trial of manualized CBT/MET for treating comorbid MDD/AUD adolescents. Large multi-site studies are warranted to further clarify the efficacy of CBT/MET therapy among various adolescent and young adult comorbid populations.

KW - Adolescents

KW - Alcohol use disorder

KW - Cognitive behavioral therapy

KW - Comorbidity

KW - Major depression

KW - Motivational enhancement therapy

UR - http://www.scopus.com/inward/record.url?scp=79955721433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955721433&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2011.03.016

DO - 10.1016/j.addbeh.2011.03.016

M3 - Article

C2 - 21530092

AN - SCOPUS:79955721433

VL - 36

SP - 843

EP - 848

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 8

ER -